99 related articles for article (PubMed ID: 7616417)
1. Pharmacological characterization of the 5-hydroxytryptamine-1A receptor-mediated activation of high-affinity GTP hydrolysis in rat hippocampal membranes.
Odagaki Y; Fuxe K
J Pharmacol Exp Ther; 1995 Jul; 274(1):337-44. PubMed ID: 7616417
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
Odagaki Y; Toyoshima R
Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
4. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
5. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
7. Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats.
Clarke WP; Yocca FD; Maayani S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1259-66. PubMed ID: 8667186
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
9. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
10. Native rat hippocampal 5-HT1A receptors show constitutive activity.
Martel JC; Ormière AM; Leduc N; Assié MB; Cussac D; Newman-Tancredi A
Mol Pharmacol; 2007 Mar; 71(3):638-43. PubMed ID: 17167032
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.
Rënyi L; Evenden JL; Fowler CJ; Jerning E; Kelder D; Lake-Bakaar D; Larsson LG; Mohell N; Sällemark M; Ross SB
J Pharmacol Exp Ther; 2001 Dec; 299(3):883-93. PubMed ID: 11714872
[TBL] [Abstract][Full Text] [Related]
12. 5-HT1A receptor-mediated activation of high-affinity GTPase in rat hippocampal membranes.
Odagaki Y; Fuxe K
Eur J Pharmacol; 1995 Feb; 288(3):385-8. PubMed ID: 7774684
[TBL] [Abstract][Full Text] [Related]
13. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
Odagaki Y; Nishi N; Nakagawa S; Koyama T
J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
[TBL] [Abstract][Full Text] [Related]
15. Effects of the wasp venom peptide, mastoparan, on GTP hydrolysis in rat brain membranes.
Odagaki Y; Nishi N; Koyama T
Br J Pharmacol; 1997 Aug; 121(7):1406-12. PubMed ID: 9257921
[TBL] [Abstract][Full Text] [Related]
16. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
17. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
18. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
De Vivo M; Maayani S
Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
[TBL] [Abstract][Full Text] [Related]
19. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
Varrault A; Journot L; Audigier Y; Bockaert J
Mol Pharmacol; 1992 Jun; 41(6):999-1007. PubMed ID: 1614416
[TBL] [Abstract][Full Text] [Related]
20. Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons.
Lin CH; Huang YC; Tsai JJ; Gean PW
Synapse; 2001 Sep; 41(4):351-9. PubMed ID: 11494406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
